Journal of Translational Medicine · 2004 · 162 citations · 71 references
MedicineCell BiologyOncologyMolecular OncologyTumor MicroenvironmentTumor ProgressionAngiogenesisAngiogenesis In CancerCancer ImmunotherapyEndothelial ProliferationTherapeutic Target IdentificationTherapeutic Target ValidationTumor Vasculature Targeting
Antibody targeting of tumor-associated vasculature is a promising therapeutic approach in human cancer; however, a specific cell membrane marker for endothelial cells of tumor vasculature has not been discovered yet. Endoglin (CD105) is a cell-surface glycoprotein most recently identified as an optimal indicator of proliferation of human endothelial cells. The finding that CD105 is over-expressed on vascular endothelium in angiogenetic tissues has prompted several pre-clinical studies designed to get a deeper understanding on the role of CD105 in angiogenesis, and to evaluate the most appropriate clinical setting(s) to utilize CD105 as a therapeutic target. In this review, the foreseeable clinical applications of CD105 in human cancer are discussed.
71
Role of angiogenesis in patients with cerebral ischemic stroke.
Jerzy Krupiński, J Kałuza, P. Kumar et al. · Stroke · 1994 · 880 citations · Full text
Medicine, Neurology, Neuroscience +17
Defective Angiogenesis in Mice Lacking Endoglin
Dean Y. Li, Lise K. Sorensen, Benjamin S. Brooke et al. · Science · 1999 · 858 citations